[at Motley Fool] – Eli Lilly is facing a perfect storm. Its lead product, the antidepressant Cymbalta will lose its U.S. patent exclusivity this week while its late stage phase 3 wildcating has been producing dry holes.
Read more on … [visit site to read more]
Eli Lilly and Company (NYSE:LLY) – Eli Lilly: Fasten Your Seat Belts for a Bumpy Ride
December 10, 2013 at 15:06 PM EST
[at Motley Fool] – Eli Lilly is facing a perfect storm. Its lead product, the antidepressant Cymbalta will lose its U.S. patent exclusivity this week while its late stage phase 3 wildcating has . . . → Read More: Eli Lilly and Company (NYSE:LLY) – Eli Lilly: Fasten Your Seat Belts for a Bumpy Ride Similar posts: 2013: The wildest ride of our lifetime! Japan Steel Works in the cuckoo bird seat Boeing’s Double Top: Will the company continue to soar?
